Chemoinformaics analysis of alpha-Bisabololbeta-D-fucopyranoside
| Molecular Weight | 911.092 | nRot | 9 |
| Heavy Atom Molecular Weight | 836.5 | nRig | 49 |
| Exact Molecular Weight | 910.493 | nRing | 9 |
| Solubility: LogS | -3.848 | nHRing | 5 |
| Solubility: LogP | 2.107 | No. of Aliphatic Rings | 9 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 138 | No. of Aliphatic Hetero Cycles | 5 |
| No. of Heavy Atom | 64 | No. of Aromatic Carbocycles | 0 |
| nHetero | 17 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 74 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 47 | No. of Saturated Rings | 8 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 17 | No. of Arom Bond | 0 |
| nHA | 17 | APOL | 141.467 |
| nHD | 7 | BPOL | 90.7293 |
| QED | 0.166 |
| Synth | 6.636 |
| Natural Product Likeliness | 1.706 |
| NR-PPAR-gamma | 0.504 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.019 |
| Pgp-sub | 0.023 |
| HIA | 0.202 |
| CACO-2 | -5.845 |
| MDCK | 0.000176371 |
| BBB | 0.054 |
| PPB | 0.589302 |
| VDSS | 0.194 |
| FU | 0.108848 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.406 |
| CYP2c19-inh | 0.001 |
| CYP2c19-sub | 0.344 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.051 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.16 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.61 |
| CL | 17.172 |
| T12 | 0.018 |
| hERG | 0.454 |
| Ames | 0.091 |
| ROA | 0.998 |
| SkinSen | 0.05 |
| Carcinogencity | 0.084 |
| EI | 0.003 |
| Respiratory | 0.844 |
| NR-Aromatase | 0.796 |
| Antiviral | Yes |
| Prediction | 0.786694 |